Skip to content
10-Q

Quarterly Report

COLLEGIUM PHARMACEUTICAL, INC COLL

0001628280-26-031697

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 32.43M sh
Shares Diluted Q1 2026 · Mar 31, 2026 40.07M sh
Shares Diluted Q1 2026 · Mar 31, 2025 32.84M sh
Capex Q1 2026 · Mar 31, 2026 $270K
Capex Q1 2026 · Mar 31, 2025 $798K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $57.11M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $55.4M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $268.65M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $231.25M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $96.19M
Stockholders Equity Q1 2026 · Mar 31, 2026 $312.42M
Stockholders Equity Q1 2026 · Dec 31, 2025 $301.68M
Stockholders Equity Q1 2026 · Mar 31, 2025 $234.43M
Stockholders Equity Q1 2026 · Dec 31, 2024 $228.84M
Current Liabilities Q1 2026 · Mar 31, 2026 $434.97M
Current Liabilities Q1 2026 · Dec 31, 2025 $440.03M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.34B
Total Liabilities Q1 2026 · Dec 31, 2025 $1.36B
Current Assets Q1 2026 · Mar 31, 2026 $745.67M
Current Assets Q1 2026 · Dec 31, 2025 $691.41M
Total Assets Q1 2026 · Mar 31, 2026 $1.65B
Total Assets Q1 2026 · Dec 31, 2025 $1.66B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.40
Eps Diluted Q1 2026 · Mar 31, 2025 $0.07
Eps Basic Q1 2026 · Mar 31, 2026 $0.45
Eps Basic Q1 2026 · Mar 31, 2025 $0.08
Sga Expense Q1 2026 · Mar 31, 2026 $86.35M
Sga Expense Q1 2026 · Mar 31, 2025 $76.42M
Net Income Q1 2026 · Mar 31, 2026 $14.5M
Net Income Q1 2026 · Mar 31, 2025 $2.42M
Operating Income Q1 2026 · Mar 31, 2026 $30.9M
Operating Income Q1 2026 · Mar 31, 2025 $21.69M
Gross Profit Q1 2026 · Mar 31, 2026 $117.25M
Gross Profit Q1 2026 · Mar 31, 2025 $97.32M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $76.27M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $80.43M
Revenue Q1 2026 · Mar 31, 2026 $193.52M
Revenue Q1 2026 · Mar 31, 2025 $177.76M